Literature DB >> 12219003

Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access.

Abraham J Sorom1, Christopher B Hughes, James T McCarthy, Bernice M Jenson, Mikel Prieto, Jean M Panneton, Sylvester Sterioff, Mark D Stegall, Scott L Nyberg.   

Abstract

BACKGROUND: A cuffed expanded polytetrafluoroethylene (ePTFE) hemodialysis graft was developed to address the problem of recurrent stenosis at the graft-vein anastomosis. The purpose of this study was to compare graft patency and blood flow rates of cuffed and noncuffed (standard) ePTFE grafts placed for hemodialysis access.
METHODS: Forty-eight patients were prospectively randomized and followed for up to 24 months after placement of a cuffed or standard ePTFE graft for hemodialysis access. Study end points included time to graft failure and blood flow rates on hemodialysis.
RESULTS: Risk factors for graft failure were similar in both groups. However, the overall incidence of graft failure was significantly lower in the cuffed ePTFE graft group (P =.039). Graft patency rates in the cuffed versus standard groups were 64% versus 32% at 12 months (P =.037) and 58% versus 21% at 24 months (P =.0213). No cuffed ePTFE graft failed as a result of venous outflow stenosis. Average graft flow rates were similar when first measured 3 months postoperatively (845 mL/min, cuffed vs 715 mL/min, standard; P =.51) but declined more rapidly in the standard group (12 months, 623 vs 253 mL/min [P =.037]; 24 months, 531 vs 121 mL/min [P =.012]).
CONCLUSIONS: The cuffed ePTFE graft was associated with increased blood flow rates during hemodialysis and improved graft patency compared with a standard ePTFE graft. Our results suggest a beneficial effect of the cuffed venous geometry for hemodialysis vascular access.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12219003     DOI: 10.1067/msy.2002.124932

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Long-term outcome of a cuffed expanded PTFE graft for hemodialysis vascular access.

Authors:  George Tsoulfas; Martin Hertl; Dicken S C Ko; Nahel Elias; Francis L Delmonico; Linda Romano; Isabel Fernandes; David Schoenfeld; Tatsuo Kawai
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

2.  Patency rates of cuffed and noncuffed extended polytetrafluoroethylene grafts in dialysis access: a prospective, randomized study.

Authors:  Po-Jen Ko; Yun-Hen Liu; Yen-Ni Hung; Hung-Chang Hsieh
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 3.  [Vascular grafts as access for hemodialysis].

Authors:  J Zanow; U Settmacher
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

4.  Impact of cuffed, expanded polytetrafluoroethylene dialysis grafts on graft outlet stenosis.

Authors:  Yun-Hen Liu; Yen-Ni Hung; Hung-Chang Hsieh; Po-Jen Ko
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

Review 5.  Coronary artery bypass grafting hemodynamics and anastomosis design: a biomedical engineering review.

Authors:  Dhanjoo N Ghista; Foad Kabinejadian
Journal:  Biomed Eng Online       Date:  2013-12-13       Impact factor: 2.819

6.  A pilot study comparing bovine mesenteric artery and expanded polytetrafluoroethylene grafts as non-autogenous hemodialysis options.

Authors:  Bruno Morisson; Antonio Luiz de Araújo; Leonardo de Oliveira Harduin; Eglina Filgueiras Porcari; Rossano Kepler Alvim Fiorelli; Stenio Karlos Alvim Fiorelli; Jose Marcos Braz Serafim; Julio Cesar Peclat de Oliveira
Journal:  J Vasc Bras       Date:  2018 Oct-Dec

7.  Midterm experience of ipsilateral axillary-axillary arteriovenous loop graft as tertiary access for haemodialysis.

Authors:  J P Hunter; M L Nicholson
Journal:  J Transplant       Date:  2014-03-23

8.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.